IDO Vaccine Ablates Immune-Suppressive Myeloid Populations and Enhances Antitumor Effects Independent of Tumor Cell IDO Status

Skip Nav Destination

Cancer Immunol Res (2022) 10 (5): 571–580.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

New Vaccine Therapy for Triple-Negative Breast Cancer

Paul E. Harris
Reid Rubsamen

Current Breast Cancer Reports (2024) 16 (3): 288.

State-Of-The-Art Advancements on Cancer Vaccines and Biomarkers

Scott Strum
Mads Hald Andersen
Inge Marie Svane
Lillian L. Siu
Jeffrey S. Weber

American Society of Clinical Oncology Educational Book (2024) 44 (3)

New insights for the development of efficient DNA vaccines

Simone Berger
Yanira Zeyn
Ernst Wagner
Matthias Bros

Microbial Biotechnology (2024) 17 (11)

An overview of immunotoxicity in drug discovery and development

Rahul M. Nandre
Pramod S. Terse

Toxicology Letters (2024)

Immune modulatory vaccines: time to move into infectious diseases

Mads Hald Andersen

The Lancet Microbe (2023) 4 (1): e4.

Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy

Rasmus Erik Johansson Mortensen
Morten Orebo Holmström
Thomas Landkildehus Lisle
Jane P Hasselby
Gro L Willemoe
Özcan Met
Inge Marie Svane
Julia Johansen
Dorte L Nielsen
Inna M Chen
Mads Hald Andersen

Journal for ImmunoTherapy of Cancer (2023) 11 (3): e006432.

Strategies to overcome myeloid cell induced immune suppression in the tumor microenvironment

Jennifer Cao
Lyndah Chow
Steven Dow

Frontiers in Oncology (2023) 13

Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target

Feyza Gul Ozbay Kurt
Samantha Lasser
Ihor Arkhypov
Jochen Utikal
Viktor Umansky

Journal of Clinical Investigation (2023) 133 (13)

Interrelation between Programmed Cell Death and Immunogenic Cell Death: Take Antitumor Nanodrug as an Example

Qi Meng
Binbin Ding
Ping'an Ma
Jun Lin

Small Methods (2023) 7 (5)

Cancer Vaccine Therapeutics: Limitations and Effectiveness—A Literature Review

Mariusz Kaczmarek
Justyna Poznańska
Filip Fechner
Natasza Michalska
Sara Paszkowska
Adrianna Napierała
Andrzej Mackiewicz

Cells (2023) 12 (17): 2159.

Tumor microenvironment antigens

Mads Hald Andersen

Seminars in Immunopathology (2023) 45 (2): 253.

Metabolic guidance and stress in tumors modulate antigen-presenting cells

Jaeoh Park
Limei Wang
Ping-Chih Ho

Oncogenesis (2022) 11 (1)

YH29407 with anti-PD-1 ameliorates anti-tumor effects via increased T cell functionality and antigen presenting machinery in the tumor microenvironment

Dong Kwon Kim
Chun-Bong Synn
Seung Min Yang
Seongsan Kang
Sujeong Baek
Se-Woong Oh
Gyu-Jin Lee
Ho-Woong Kang
Young-Sung Lee
Jong Suk Park
Jae Hwan Kim
Youngseon Byeon
Young Seob Kim
Doo Jae Lee
Hyun-Woo Kim
June Dong Park
Sung Sook Lee
Ji Yun Lee
Jii Bum Lee
Chang Gon Kim
Min Hee Hong
Sun Min Lim
Hey Ryun Kim
Kyoung-Ho Pyo
Byoung Chul Cho

Frontiers in Chemistry (2022) 10

The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers

Rong Fan
Nathan De Beule
Anke Maes
Elke De Bruyne
Eline Menu
Karin Vanderkerken
Ken Maes
Karine Breckpot
Kim De Veirman

Frontiers in Immunology (2022) 13

Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation

Chiel van Geffen
Constantin Heiss
Astrid Deißler
Saeed Kolahian

Frontiers in Immunology (2022) 13

IDO Vaccine Ablates Immune-Suppressive Myeloid Populations and Enhances Antitumor Effects Independent of Tumor Cell IDO Status

AACR Journals

This Feature Is Available To Subscribers Only